Lab Med Online.  2023 Apr;13(2):78-84. 10.47429/lmo.2023.13.2.78.

Performance Evaluation of QMAC-dRAST Using Consecutive Positive Clinical Blood Culture Samples

• Choi H
• Kim D
• Kwon M
• Byun JH
• Jin B
• Hong KH
• Lee H
• Yong D

• KMID: 2552729
• DOI: http://doi.org/10.47429/lmo.2023.13.2.78

Abstract

Background
Bacteremia is life-threatening to patients, with a case fatality rate of 30–40%. The QMAC-dRAST system (QuantaMatrix, Republic of Korea), which is based on time-lapse imaging technology, can generate antimicrobial susceptibility testing (AST) results earlier than conventional equipment. Here, we evaluated the performance of QMAC-dRAST for positive blood culture samples.
Methods
In total, 204 isolates were collected from positive blood cultures, with 104 Gram-positive cocci (GPC) and 100 Gram-negative rods (GNR), including Staphylococcus spp., Enterococcus spp., Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter spp. Before and after improvement of the AST algorithm, 67 GPC isolates and 72 GNR isolates were tested and their results were compared. In the final test, 37 GPC and 28 GNR were added, and the agreement rates between QMAC-dRAST and Vitek 2 were analyzed using 204 samples. To resolve discrepant AST results between two systems, broth microdilution tests were performed.
Results
In the first and second tests with 67 GPC and 72 GNR, the categorical agreement (CA) between QMAC-dRAST and Vitek 2 was increased from 92.7% and 96.2% to 94.3% and 96.5% by updating the AST algorithm, respectively. For all 204 samples, the agreement rates were 94.5% and 95.4% for CA; 4.8% and 0.6% for very major errors; 2.5% and 2.0% for major errors; and 2.1% and 3.0% for minor errors.
Conclusions
The QMAC-dRAST system has reliable performance and the advantage of faster AST reporting than conventional methods. This system will demonstrate more acceptable agreement rates with conventional AST systems in the future by improving AST algorithms.

Keyword

Antimicrobial susceptibility testing; Blood culture; Bacteremia

Reference

1. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. 2000; The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 118:146–55. DOI: 10.1378/chest.118.1.146. PMID: 10893372.

2. Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD. 1995; Long-term survival following bacteremia or fungemia. JAMA. 274:807–12. DOI: 10.1001/jama.1995.03530100047033. PMID: 7650804.

3. Lee Y, Kim YA, Song W, Lee H, Lee HS, Jang SJ, et al. 2013; Recent trends in antimicrobial resistance in intensive care units in Korea. Korean J Nosocomial Infect Control. 19:29–36. DOI: 10.14192/kjnic.2014.19.1.29.

4. Liu C, Yoon EJ, Kim D, Shin JH, Shin JH, Shin KS, et al. 2019; Antimicrobial resistance in South Korea: A report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017. Infect Chemother. 25:845–59. DOI: 10.1016/j.jiac.2019.06.010. PMID: 31311694.

5. Seo YH, Jeong JH, Lee HT, Kwoun WJ, Park PW, Ahn JY, et al. 2017; Analysis of blood culture data at a tertiary university hospital, 2006-2015. Ann Clin Microbiol. 20:35–41. DOI: 10.5145/ACM.2017.20.2.35.

6. Park ES, Jin HY, Jeong SY, Kweon OM, Yoo SY, Park SY, et al. 2011; Healthcare-associated infection surveillance in small and medium sized hospitals. Korean J Nosocomial Infect Control. 16:54–62.

7. Lee HG, Jang J, Choi JE, Chung DC, Han JW, Woo H, et al. 2013; Blood stream infections in patients in the burn intensive care unit. Infect Chemother. 45:194–201. DOI: 10.3947/ic.2013.45.2.194. PMID: 24265967. PMCID: PMC3780961.

8. van Belkum A, Burnham CD, Rossen JWA, Mallard F, Rochas O, Dunne WM Jr. 2020; Innovative and rapid antimicrobial susceptibility testing systems. Nat Rev Microbiol. 18:299–311. DOI: 10.1038/s41579-020-0327-x. PMID: 32055026.

9. Quesada MD, Giménez M, Molinos S, Fernández G, Sánchez MD, Rivelo R, et al. 2010; Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles. Clin Microbiol Infect. 16:137–40. DOI: 10.1111/j.1469-0691.2009.02907.x. PMID: 19778301.

10. Choi J, Jeong HY, Lee GY, Han S, Han S, Jin B, et al. 2017; Direct, rapid antimicrobial susceptibility test from positive blood cultures based on microscopic imaging analysis. Sci Rep. 7:1148. DOI: 10.1038/s41598-017-01278-2. PMID: 28442767. PMCID: PMC5430693.

11. Choi J, Jung YG, Kim J, Kim S, Jung Y, Na H, et al. 2013; Rapid antibiotic susceptibility testing by tracking single cell growth in a microfluidic agarose channel system. Lab Chip. 13:280–7. DOI: 10.1039/C2LC41055A. PMID: 23172338.

12. Wang HY, Uh Y, Kim S, Lee H. 2017; Quantamatrix Multiplexed Assay Platform system for direct detection of bacteria and antibiotic resistance determinants in positive blood culture bottles. Clin Microbiol Infect. 23:333.e1–7. DOI: 10.1016/j.cmi.2016.12.013. PMID: 27998819.

13. Kim JH, Kim TS, Song SH, Choi J, Han S, Kim DY, et al. 2018; Direct rapid antibiotic susceptibility test (dRAST) for blood culture and its potential usefulness in clinical practice. J Med Microbiol. 67:325–31. DOI: 10.1099/jmm.0.000678. PMID: 29458541.

14. Grohs P, Rondinaud E, Fourar M, Rouis K, Mainardi JL, Podglajen I. 2020; Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates. J Microbiol Methods. 172:105902. DOI: 10.1016/j.mimet.2020.105902. PMID: 32205178.

15. Huh HJ, Song DJ, Shim HJ, Kwon WK, Park MS, Ryu MR, et al. 2018; Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture: a comparative study of performance with the VITEK-2 system. J Antimicrob Chemother. 73:1267–71. DOI: 10.1093/jac/dky015. PMID: 29415214.

16. Kim H, Jeong HY, Han S, Han S, Choi J, Jin B, et al. 2018; Clinical Evaluation of QMAC-dRAST for Direct and Rapid Antimicrobial Susceptibility Test with Gram-Positive Cocci from Positive Blood Culture Bottles. Ann Clin Microbiol. 21:12–9. DOI: 10.5145/ACM.2018.21.1.12.

17. Clinical, Laboratory Standards Institute. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 11th ed. CLSI standard M07. Wayne, PA: Clinical and Laboratory Standards Institute.

18. U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health. Antimicrobial Susceptibility Test (AST) Systems - Class II special controls guidance for Industry and FDA. https://www.fda.gov/medical-devices/guidance-documents-medical-devices-and-radiation-emitting-products/antimicrobial-susceptibility-test-ast-systems-class-ii-special-controls-guidance-industry-and-fda#1. Updated on Feb 2018.

19. van Belkum A, Burnham CD, Rossen JWA, Mallard F, Rochas O, Dunne WM Jr. 2020; Innovative and rapid antimicrobial susceptibility testing systems. Nat Rev Microbiol. 18:299–311. DOI: 10.1038/s41579-020-0327-x. PMID: 32055026.

20. Jin WY, Jang SJ, Lee MJ, Park G, Kim MJ, Kook JK, et al. 2011; Evaluation of VITEK 2, MicroScan, and Phoenix for identification of clinical isolates and reference strains. Diagn Microbiol Infect Dis. 70:442–7. DOI: 10.1016/j.diagmicrobio.2011.04.013. PMID: 21767700.

21. Banerjee R, Humphries R. 2021; Rapid antimicrobial susceptibility testing methods for blood cultures and their clinical impact. Front Med (Lausanne). 8:635831. DOI: 10.3389/fmed.2021.635831. PMID: 33777978. PMCID: PMC7987685.

22. Gaynes R, Edwards JR. 2005; Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 41:848–54. DOI: 10.1086/432803. PMID: 16107985.

23. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R, et al. 2006; Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 42:389–91. DOI: 10.1086/499367. PMID: 16392087.

24. Ramsey AM, Zilberberg MD. 2009; Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol. 30:184–6. DOI: 10.1086/593956. PMID: 19125679.

25. Lee K. 2011; Trend of bacterial resistance for the past 50 years in Korea and future perspectives-gram-negative bacteria. Infect Chemother. 43:458–67. DOI: 10.3947/ic.2011.43.6.458.